HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

Abstract
Few studies have examined the relationship between human leukocyte antigen (HLA) polymorphisms and adult glioma, particularly at class II loci. We evaluated the association between selected HLA class II polymorphisms and adult glioma in a large, hospital-based case-control study, using unconditional logistic regression. DQB1 06 (OR=1.67, 95% CI=1.17-2.39) and DRB1 13 (OR=1.69, 95% CI=1.08-2.64) alleles were associated with an increased risk of glioma, while the DQB1 05 allele showed an inverse association (OR=0.63, 95% CI=0.43-0.93). These results, which were of borderline significance once controlled for the false discovery rate, suggest a potential role for the DQB1 06, DQB1 05, and DRB1 13 alleles in glioma susceptibility.
AuthorsBryan A Bassig, Peter D Inskip, Laurie Burdette, William R Shapiro, Robert G Selker, Howard A Fine, Jay S Loeffler, Peter M Black, Robert Dubrow, Alina V Brenner
JournalJournal of neuroimmunology (J Neuroimmunol) Vol. 233 Issue 1-2 Pg. 185-91 (Apr 2011) ISSN: 1872-8421 [Electronic] Netherlands
PMID21195488 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
CopyrightCopyright © 2010. Published by Elsevier B.V.
Chemical References
  • HLA-DQ Antigens
  • HLA-DQ beta-Chains
  • HLA-DQB1 antigen
  • HLA-DR Antigens
  • HLA-DRB1 Chains
Topics
  • Adult
  • Aged
  • Brain Neoplasms (genetics, immunology)
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease (genetics)
  • Glioma (genetics, immunology)
  • HLA-DQ Antigens (genetics)
  • HLA-DQ beta-Chains
  • HLA-DR Antigens (genetics)
  • HLA-DRB1 Chains
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Genetic (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: